What if … cutting-edge cancer radiation therapy didn’t have to cost so much? If patients and their families didn’t have to travel to a centralised cancer care centre for the best treatment?
Nano-X is an innovative cancer treatment system being designed and developed in Australia. Nano-X will change the delivery of radiation therapy from large reference centres to small-town hospitals. An advanced on-board imaging/planning system captures 3D images in real-time, controls the radiation beam, and automatically delivers the right amount of energy to the right tissue. It requires fewer dedicated staff.
Dr Ilana Feain (PhD Physics) is founder and CEO of Nano-X. She leads all aspects of the technology development and is also a senior research fellow in the School of Medicine at the University of Sydney. Ilana is also a world-renowned astrophysicist and the recipient of the Inaugural L’OREAL Australia Women in Science Fellowship.
Professor Paul Keall is founder and Director of Nano-X. He leads the Radiation Physics Lab at the University of Sydney where much of the Nano-X technology was invented. Paul is a serial inventor in real-time radiation therapy, and is widely regarded internationally as a thought leader in this field.
Professor Thomas “Rock” Mackie is an indefatigable innovator, entrepreneur and key opinion leader in medical physics. Among his many commercial successes, Professor Mackie co-founded Tomotherapy and Geometric Corp and has 47 issued patents.
Ben Wright is the Chief Innovations Officer and Head of Investment Strategy at ATP Innovations. Ben is also Director of the Medical Device Commercialisation Training Program and founder of two seed accelerator programs. He has worked in the commercialisation space for more than 15 years, holding numerous research and management positions across life science businesses.